Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:raom01

Total Results:

52


Dissociation of Axonal Neurofilament Content from Its Transport Rate

Yuan, Aidong; Hassinger, Linda; Rao, Mala V; Julien, Jean-Pierre; Miller, Christopher C J; Nixon, Ralph A
The axonal cytoskeleton of neurofilament (NF) is a long-lived network of fibrous elements believed to be a stationary structure maintained by a small pool of transported cytoskeletal precursors. Accordingly, it may be predicted that NF content in axons can vary independently from the transport rate of NF. In the present report, we confirm this prediction by showing that human NFH transgenic mice and transgenic mice expressing human NFL Ser55 (Asp) develop nearly identical abnormal patterns of NF accumulation and distribution in association with opposite changes in NF slow transport rates. We also show that the rate of NF transport in wild-type mice remains constant along a length of the optic axon where NF content varies 3-fold. Moreover, knockout mice lacking NFH develop even more extreme (6-fold) proximal to distal variation in NF number, which is associated with a normal wild-type rate of NF transport. The independence of regional NF content and NF transport is consistent with previous evidence suggesting that the rate of incorporation of transported NF precursors into a metabolically stable stationary cytoskeletal network is the major determinant of axonal NF content, enabling the generation of the striking local variations in NF number seen along axons.
PMCID:4514674
PMID: 26208164
ISSN: 1932-6203
CID: 1684182

Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo

Yuan, A; Sershen, H; Veeranna; Basavarajappa, B S; Kumar, A; Hashim, A; Berg, M; Lee, J-H; Sato, Y; Rao, M V; Mohan, P S; Dyakin, V; Julien, J-P; Lee, V M-Y; Nixon, R A
Synaptic roles for neurofilament (NF) proteins have rarely been considered. Here, we establish all four NF subunits as integral resident proteins of synapses. Compared with the population in axons, NF subunits isolated from synapses have distinctive stoichiometry and phosphorylation state, and respond differently to perturbations in vivo. Completely eliminating NF proteins from brain by genetically deleting three subunits (alpha-internexin, NFH and NFL) markedly depresses hippocampal long-term potentiation induction without detectably altering synapse morphology. Deletion of NFM in mice, but not the deletion of any other NF subunit, amplifies dopamine D1-receptor-mediated motor responses to cocaine while redistributing postsynaptic D1-receptors from endosomes to plasma membrane, consistent with a specific modulatory role of NFM in D1-receptor recycling. These results identify a distinct pool of synaptic NF subunits and establish their key role in neurotransmission in vivo, suggesting potential novel influences of NF proteins in psychiatric as well as neurological states.
PMCID:4514553
PMID: 25869803
ISSN: 1476-5578
CID: 1684462

Functions of neurofilaments in synapses

Yuan, A; Sershen, H; Veeranna; Basavarajappa, B S; Kumar, A; Hashim, A; Berg, M; Lee, J-H; Sato, Y; Rao, M V; Mohan, P S; Dyakin, V; Julien, J-P; Lee, V M-Y; Nixon, R A
PMID: 26201270
ISSN: 1476-5578
CID: 1683992

Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity

Menzies, F M; Garcia-Arencibia, M; Imarisio, S; O'Sullivan, N C; Ricketts, T; Kent, B A; Rao, M V; Lam, W; Green-Thompson, Z W; Nixon, R A; Saksida, L M; Bussey, T J; O'Kane, C J; Rubinsztein, D C
Over recent years, accumulated evidence suggests that autophagy induction is protective in animal models of a number of neurodegenerative diseases. Intense research in the field has elucidated different pathways through which autophagy can be upregulated and it is important to establish how modulation of these pathways impacts upon disease progression in vivo and therefore which, if any, may have further therapeutic relevance. In addition, it is important to understand how alterations in these target pathways may affect normal physiology when constitutively modulated over a long time period, as would be required for treatment of neurodegenerative diseases. Here we evaluate the potential protective effect of downregulation of calpains. We demonstrate, in Drosophila, that calpain knockdown protects against the aggregation and toxicity of proteins, like mutant huntingtin, in an autophagy-dependent fashion. Furthermore, we demonstrate that, overexpression of the calpain inhibitor, calpastatin, increases autophagosome levels and is protective in a mouse model of Huntington's disease, improving motor signs and delaying the onset of tremors. Importantly, long-term inhibition of calpains did not result in any overt deleterious phenotypes in mice. Thus, calpain inhibition, or activation of autophagy pathways downstream of calpains, may be suitable therapeutic targets for diseases like Huntington's disease.
PMCID:4326573
PMID: 25257175
ISSN: 1350-9047
CID: 1462922

Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]alphaSyn transgenic mice

Diepenbroek, Meike; Casadei, Nicolas; Esmer, Hakan; Saido, Takaomi C; Takano, Jiro; Kahle, Philipp J; Nixon, Ralph A; Rao, Mala V; Melki, Ronald; Pieri, Laura; Helling, Stefan; Marcus, Katrin; Krueger, Rejko; Masliah, Eliezer; Riess, Olaf; Nuber, Silke
Lewy bodies, a pathological hallmark of Parkinson's disease (PD), contain aggregated alpha-synuclein (alphaSyn), which is found in several modified forms and can be discovered phosphorylated, ubiquitinated and truncated. Aggregation-prone truncated species of alphaSyn caused by aberrant cleavage of this fibrillogenic protein are hypothesized to participate in its sequestration into inclusions subsequently leading to synaptic dysfunction and neuronal death. Here, we investigated the role of calpain cleavage of alphaSyn in vivo by generating two opposing mouse models. We crossed into human [A30P]alphaSyn transgenic (i) mice deficient for calpastatin, a calpain-specific inhibitor, thus enhancing calpain activity (SynCAST(-)) and (ii) mice overexpressing human calpastatin leading to reduced calpain activity (SynCAST(+)). As anticipated, a reduced calpain activity led to a decreased number of alphaSyn-positive aggregates, whereas loss of calpastatin led to increased truncation of alphaSyn in SynCAST(-). Furthermore, overexpression of calpastatin decreased astrogliosis and the calpain-dependent degradation of synaptic proteins, potentially ameliorating the observed neuropathology in [A30P]alphaSyn and SynCAST(+) mice. Overall, our data further support a crucial role of calpains, particularly of calpain 1, in the pathogenesis of PD and in disease-associated aggregation of alphaSyn, indicating a therapeutic potential of calpain inhibition in PD.
PMCID:4110482
PMID: 24619358
ISSN: 0964-6906
CID: 1085982

Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice

Rao, Mala V; McBrayer, Mary Kate; Campbell, Jabbar; Kumar, Asok; Hashim, Audrey; Sershen, Henry; Stavrides, Philip H; Ohno, Masuo; Hutton, Michael; Nixon, Ralph A
Tau pathogenicity in Alzheimer's disease and other tauopathies is thought to involve the generation of hyperphosphorylated, truncated, and oligomeric tau species with enhanced neurotoxicity, although the generative mechanisms and the implications for disease therapy are not well understood. Here, we report a striking rescue from mutant tau toxicity in the JNPL3 mouse model of tauopathy. We show that pathological activation of calpains gives rise to a range of potentially toxic forms of tau, directly, and by activating cdk5. Calpain overactivation in brains of these mice is accelerated as a result of the marked depletion of the endogenous calpain inhibitor, calpastatin. When levels of this inhibitor are restored in neurons of JNPL3 mice by overexpressing calpastatin, tauopathy is prevented, including calpain-mediated breakdown of cytoskeletal proteins, cdk5 activation, tau hyperphosphorylation, formation of potentially neurotoxic tau fragments by either calpain or caspase-3, and tau oligomerization. Calpastatin overexpression also prevents loss of motor axons, delays disease onset, and extends survival of JNPL3 mice by 3 months to within the range of normal lifespan. Our findings support the therapeutic promise of highly specific calpain inhibition in the treatment of tauopathies and other neurodegenerative states.
PMCID:4087203
PMID: 25009256
ISSN: 0270-6474
CID: 1074822

Immunofocusing to HIV's V2 Loop C beta-Strand [Meeting Abstract]

Shmelkov, S. ; Rao, M. ; Wang, S. ; Kong, X. ; Lu, S. ; Cardozo, T.
ISI:000326037500365
ISSN: 0889-2229
CID: 657092

Comparable Antigenicity and Immunogenicity of Multimeric Forms of a Novel, Acute HIV-1 Subtype C Gp145 Envelope for Clinical Development [Meeting Abstract]

Wieczorek, L. ; Krebs, S. ; Kalyanaraman, V. ; Whitney, S. ; Matyas, G. R. ; Rao, M. ; Alving, C. R. ; Tong, T. ; Molnar, S. ; Wesberry, M. ; Chenine, A. Laurence ; Tovanabutra, S. ; Sanders-Buell, E. ; Slike, B. ; Alam, S. ; Liao, H. ; Haynes, B. F. ; Williams, C. ; Zolla-Pazner, S. ; Moscoso, C. ; Cheng, H. ; Hoelscher, M. ; Maboko, L. ; Michael, N. ; Robb, M. L. ; VanCott, T. ; Marovich, M. ; Polonis, V.
ISI:000326037500066
ISSN: 0889-2229
CID: 657022

Role of vaccine-induced V2 antibodies in protection from HIV infection of recipients in the RV144 clinical vaccine trial [Meeting Abstract]

Zolla-Pazner, S; Williams, C; De, Camp A; Morris, D; Haynes, B; Kim, J; Michael, N; Rao, M
Objective: Determine the role of V2 antibodies (Abs) in protecting vaccinees from HIV infection after immunization with ALVAC/HIV and clade E and B recombinant gp120 (RV144 vaccine regimen). ELISA reactivity to a V1V2-gp70 fusion protein and a cyclic V2 peptide was assessed using coded plasma specimens from RV144 participants. Results showed that Ab responses were divided into tertiles (low, medium and high). Vaccinees with a high level of Abs to V1V2-gp70 had a lower rate of HIV infection than did those with a low level of Abs. Multivariate logistic regression analysis showed an estimated 71% reduction in the infecton rate for vaccinees with high vs. vaccinees with low Ab responses to V1V2-gp70 (p=0.02). Similarly, compared to the entire placebo group that was HIV- at 26 weeks, the estimated Vaccine Efficacy (VE) was 3% (p=0.91) for subjects with a low V1V2 Ab response, while the estimated VE was 58% (p=0.02) for vaccinees with high V1V2 Abs. The Abs measured by this assay appear to be specific for V2 because no V1 Abs were detected, and epitope mapping data suggest that the epitope recognized by vaccinees' Abs target the midloop region of V2. There was no statistically significant correlation between infection rate and Abs reactive with a cyclic V2 peptide containing the entire V2 loop of the clade E A244 strain. In the primary case control analysis the Ab response to V1V2-gp70 was statistically significantly inversely correlated with infection. While secondary analyses suggest that other immunologic responses (including Abs to other epitopes and cellular responses) may also play a role in protection, the data most strongly support the hypothesis that V2 Abs are important for protection
EMBASE:71184757
ISSN: 1525-4135
CID: 602642

Detection of antibodies to the alpha 4 beta 7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay [Meeting Abstract]

Rao, M.; Karasavvas, N.; Pinter, A.; Liao, H.; Bonsignori, M.; Mathieson, B.; Zolla-Pazner, S.; Haynes, B. F.; Michael, N. L.; Kim, J. H.; Alving, C. R.; Peachman, K. K.
ISI:000309472100144
ISSN: 1742-4690
CID: 181572